|Description||Bio-pharm. focused Venture Capital|
|Hatteras Venture Partners IV, 1/13||$125M|
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine.
Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to building successful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
|PhaseBio Pharmaceuticals||6/12||Series B||$23M||5|
|Clearside Biomedical||1/12||Venture Round||$4M||1|
|Clinipace WorldWide||9/11||Series C||$15M||3|
|TetraLogic Pharmaceuticals||8/10||Series C||$32M||8|
|PhaseBio Pharmaceuticals||1/10||Series B||$25M||5|
|Viamet Pharmaceuticals||7/09||Series B||$18M||6|
|SpineAlign Medical||6/08||Venture Round||$8.8M||2|
|PhaseBio Pharmaceuticals||10/07||Series B||$6.6M||3|
|Viamet Pharmaceuticals||6/07||Series A||$4M||2|